7,506
Views
23
CrossRef citations to date
0
Altmetric
Coronaviruses

Omicron: a drug developer’s perspective

&
Pages 208-211 | Received 22 Dec 2021, Accepted 22 Dec 2021, Published online: 04 Jan 2022

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.